Serum triiodothyronine (T 3 ) kinetics in man have been difficult to define presumably due to the interference of iodoproteins generated during the peripheral metabolism of T 3 . The use, in the present study, of an anion-column chromatographic method for separation of serum T 3 as well as thyroxine (T 4 ) from these iodoproteins has overcome this technical handicap.
A B S T R A C T Serum triiodothyronine (Ta) kinetics in man have been difficult to define presumably due to the interference of iodoproteins generated during the peripheral metabolism of Ts. The use, in the present study, of an anion-column chromatographic method for separation of serum Ts as well as thyroxine (Ti) from these iodoproteins has overcome this technical handicap.
Simultaneous measurement of serum 'I-Ts and 'I-T4 kinetics were performed in 31 subjects from the clinical categories of euthyroid, primary hypothyroid, thyrotoxic and posttreatment hypothyroid Graves' disease, factitial thyrotoxic, and idiopathically high and low thyroxinebinding globulin states. The normal mean Ta fractional turnover rate (kTa) was 0.68 (half-life = 1.0 days), increased in toxic Graves' disease patients to 1.10 (halflife = 0.63 days), and decreased in primary hypothyroid patients to 0.50 (half-life = 1.38 days). The mean Ts equilibration time averaged 22 hr except in hypothyroid and high thyroxine-binding globulin (TBG) patients where the equilibration period was delayed by 10 hr. The mean Ts distribution space in normal subjects was 38.4 liters. This was reduced in subjects with high TBG levels (26 liters) and increased in patients with low TBG and in all hyperthyroid states (53-55 liters). The normal serum Ta concentration was estimated by radioimmunoassay to be 0.106 u&g/100 ml. Combined with the mean Ts clearance value of 26.1 liters/day, the calculated Ta production rate was 27.6 jig/day. The mean Ts production rate increased to 201 Mg/day in thyrotoxic Graves' disease patients and was reduced to 7.6 Ig/day in primary hypothyroid subjects. Ts production rate was normal in subjects with altered TBG states. The ratio of Ts to To production rate in normal subjects was 0.31 and was unchanged in patients with altered TBG values. This ratio was increased in all Graves' disease patients with the highest value being 0.81 in the posttreatment hypothyroid Graves' disease group. This apparent preferential production of T3 may have been responsible for the retention of rapid turnover kinetics for Ts and To observed in treated Graves' disease patients. The finding that factitial thyrotoxic patients also displayed similar rapid Ts and To turnover kinetics indicates that these alterations are not a unique feature of Graves' disease per se. When comparing the peripheral turnover values for Ta and To in man, it is apparent that alterations in metabolic status and serum TBG concentration influence both hormones in a parallel manner; however, changes in metabolic status seem to have a greater influence on Ts kinetics while alterations in TBG concentrations have a greater effect on To. These observations probably relate to the differences in TBG binding affinity and peripheral tissue distribution of these two hormones.
INTRODUCTION
Since the introduction of radioactive iodine labeled thyroxine (Ti)' as a testing tool in clinical research, numerous studies of To peripheral metabolism have been performed in man (1) . By contrast, comparatively few 'Abbreviations used in this paper: DS, distribution space; kT4, triiodothyronine fractional turnover rate; kT4, thyroxine fractional turnover rate; MCR, metabolic clearance rate; RIA, radioimmunoassay; Ts, triiodothyronine; Ti, thyroxine; TBG, thyroxine-binding globulin; U, urinary.
The Journal of Clinical Investigation Volume 51 1972 473 investigations have dealt with the metabolism of triiodothyronine (Ts), and the information available is variable and at times conflicting. Early estimates of the biological half-life of Ts in euthyroid human subjects were reported to be greater than 2 days (2), while recently published values have varied between 1.30 and 1.6 days (3) (4) (5) . This difficulty in accurately assessing Ts kinetics probably relates to the generation of circulating iodoproteins appearing during Ts degradation. Surks and Oppenheimer have found that these iodoproteins appear chemically and biologically similar to serum albumin and interfere with the conventional measurements of labeled Ts in the serum (6) . While comparing the peripheral deiodination rates of labeled Ts and T4 in man (7), we have observed that the rate of Ta degradation, measured by assessing the rate of urinary excretion of radioactive label, is more rapid than the values previously cited in the literature. This observation, coupled with the iodoprotein studies of Surks and Oppenheimer (6) , stimulated our interest in assessing labeled Ts and T4 kinetics in normal subjects and in patients with alterations in thyroid status.
METHODS
The subjects employed in this investigation were from the inpatient and outpatient services of the Los Angeles County-University of Southern California Medical Center. Subject classification was established by clinical examination and conventional thyroid testing (see Table I ). The eight euthyroid control subj ects were either normal volunteers or patients with mild nonthyroidal illnesses such as duodenal ulcer or mild exogenous obesity. The six patients with primary hypothyroidism had spontaneous thyroid failure as adults. The thyrotoxic Graves' disease group was comprised of seven subjects all manifesting classic signs and symptoms of hyperthyroidism. Subjects were selected who displayed a variety of serum T. values including patients No. 6 and No. 7 who had normal serum total and free thyroxine determinations. None of the patients had been taking an antithyroid drug (methimazole) for more than 1 wk before the time of the study. The three patients with hypothyroid Graves' disease developed their hypothyroidism as a result of inadvertent overtreatment with methimazole; they had been hypothyroid for a period of 2-3 months before study and had developed gross myxedema. The three patients with factitial thyrotoxicosis had been ingesting thyroid hormone in an effort to control mild exogenous obesity and/or mental depression. Subject 1 in this group had been taking 0.9 mg L-thyroxine daily, while subjects 2 and 3 were each ingesting 9 gr of desiccated thyroid daily. In each instance, these doses of thyroid hormone had been maintained for periods in excess of 1 yr. The patients with idiopathically high and low TBG values were clinically euthyroid and in good health.
Pulse Ts and T4 tracer studies. The thyroid iodine uptake was blocked in all euthyroid and hypothyroid subjects by the administration twice daily of 5 drops of a saturated solution of potassium iodide. In addition to receiving potassium iodide, hyperthyroid subjects received 30-60 mg of methimazole in divided daily doses. Serum was drawn for stable Ts, T4, and free T4 determinations before the in-stitutions of these drugs. After establishing a thyroid blockade, 30-50 /LCi of 'I-T4 were given intravenously to initiate the study. Timed serum samples were collected twice daily for the next 7 days to measure T4 disposal rates. 2-4 days after the administration of the T. tracer, a pulse dose of 40-100 jACi of 'I-T8 was administered intravenously. Beginning 16-20 hr later, serial serum samples were drawn at 1to 2-hr intervals over a 24 to 36 hr period. In addition, serial timed urine samples were collected at approximately 2-hr intervals until the completion of the study.
The 'I-T8 and 'I-T& tracers were obtained from Industrial Nuclear Co., St. Louis, Mo.; specific activities were greater than 30 /LCi/,/g at time of injection. The purity of the radioactive tracers was verified before their administration employing a descending chromatographic paper system utilizing amyl alcohol, 2 N NH8. The labeled tracers were more than 95% pure with the majority of the contaminants being labeled iodide. The contaminating iodide was subsequently removed during the processing of the serum samples and standards and therefore did not influence the final results.
Processing of serum samples. Serum 'I-T3 and 'l1I-T4
were separated from the nonthyronine labeled materials using a 23 X 0.8 cm glass column containing 26 ml of 1.0 N NaOH were pipetted into each tube at 2-min intervals. After 5 min of incubation, each sample was poured into the anion exchange column; each tube was rinsed with approximately 1 ml distilled water which also was poured into the column. After the column had been allowed to drain, the second and third test tubes were poured into the same column in a similar manner. Thus, three successive serum samples were applied to each column. The columns were then washed successively with 1% acetic acid, three times with 15% acetic acid, and finally by 0.8 ml of glacial acetic acid and all eluates discarded. Then, 3 ml of 59% acetic acid were added to the column, the eluate collected in a counting tube, and the 'I and 125I
activities were determined in an automatic well-type scintillation counter employing a dual channel spectrometer (Baird-Atomic, Inc., Cambridge, Mass.). Initial washings of the column with 1% and 15% acetic acid served to eliminate contaminating iodoproteins from the test samples.
When a serum sample containing 'I labeled albumin was passed through the same procedure, no 'lI activity was measured in the thyronine fraction. Additionally, when a serum sample containing only .8.I-iodide was used, less than 1% appeared in the thyronine fraction. Using this procedure, the average recovery for a single run was 58.1 ±1.6% (±SD) for 'I-T8 and 54.7 ±2.1% for MI-T4. Appropriate 'I-Ts and 121I-T4 standards were prepared in pooled unlabeled serum to approximate the same level of activity as that of the test samples and were processed in a similar manner. All serum samples from study subjects were processed in one run in an effort to eliminate the interassay variability. The activities of the 'I and 'I were expressed in terms of per cent of the inj ected dose per liter and plotted against time on semilogarithmic coordinates. Calculations of the fractional turnover rates, distribution spaces, clearances, and production rates of T4 and Ts were performed as described by Sterling and Chodos (8) .
Processing of urine sample. Each urine sample was col-474 lected in a 250 ml polypropylene bottle containing 3 ml RAI 400 anion exchange resin, chloride cycle, 20-50 mesh (Mallinckrodt Chemical Works, St. Louis, Mo.). The urine was incubated in resin for 24 hr at room temperature to facilitate the uptake of labeled iodide on the resin. Each sample was decanted and the residual resin was transferred to a glass counting vial and counted in a well-type scintillation counter employing a dual channel spectrometer (Baird-Atomic, Inc., Cambridge, Mass.). Net counts for each isotope were expressed as a ratio of 'I/I and plotted on semilogarithmic coordinates against time.
Metabolic clearance by constant infusion technique. In five subjects, after completion of the T4 and T8 pulse tracer studies, the metabolic clearance of T3 was measured by techniques similar to those described by Tait and Burstein for steroids (9) . A constant infusion consisting of 1 liter of 0.9% sterile saline solution, to which 25 uCi I-Ts and 10 /ACi 18"I had been added, was administered through an indwelling polyethylene catheter or pediatric scalp vein needle into a peripheral arm vein. Human serum albumin was incorporated into the solution to a final concentration of 0.5% in order to prevent adsorption of the isotopes to the glassware and intravenous tubing. The infusion rate was approximately 2 ml/hr. A pulse loading dose of 'lI-Ts, equal in radioactivity to 48 hr of the infusion, and 'I, equal in radioactivity to 8 hr of the infusion, was given to expedite tracer equilibration. The constant infusion system employed was a portable roller-type pump (Holter R.D. 044, Holter Company, Bridgeport, Pa.). Isotopic equilibrium was determined by measuring the ratio of 'I to 'I in sequential serum secutive hourly samples, isotopic equilibration was assumed to have occurred. Generally this was observed after 14-24 hr of infusion. The subjects remained supine except when voiding urine samples.
Other laboratory studies performed. Thyroxine iodine by column and "free" thyroxine determinations were performed by Bio-Science Laboratories, Van Nuys, Calif. The maximal binding capacity of TBG was measured by the paper electrophoretic technique described by Ingbar (10). Total stable serum Ts concentrations were measured by a radioimmunoassay (RIA) method as described by Chopra, Solomon, and Beall (11) . All serum Ts determinations were performed without the knowledge of the patient source. Statistical analysis of the data was performed by a-standard t test for nonpaired groups of unequal size.
RESULTS
Serum Ts and T4 kinetic data. Fig. 1 illustrates representative examples of serum 'I-Ts disappearance slopes which were observed in euthyroid subjects and in patients with primary hypothyroidism and thyrotoxic Graves' disease. When plotted on semilogarithmic coordinates, radioactivity data from unextracted serum samples produced a nonlinear and uniformly more shallow disappearance slope than was observed in the corresponding extracted samples. Some of the '1I activity lost in the extraction procedure was 'I-iodide. However, since iodides possess a shorter biological half-life than Ta, the nonparallelism between the slopes EUTHYROID HYPERTHYROID of the data plotted from nonextracted and extracted serum could not be explained solely on this basis. The generation of 'I labeled iodoproteins from Ts would more likely account for this flattening of the disappearance curve of the unextracted sera (6) . The linearity observed in the extracted 'I-Ts serum slope suggests that such contamination had been effectively eliminated by column extraction.
In the euthyroid subjects, the daily fractional turnover rate for Ts (kTa) in the extracted serum was 67.9%. In the primary hypothyroid group, kTs decreased to 49.8%, while in the thyrotoxic Graves' and factitial hyperthyroid groups kTs increased to 110 and 98.3%, respectively. Insignificant changes in kTs were seen in the hypothyroid Graves' disease patients and subjects with idiopathic alterations in TBG. These findings are consistent with the conclusion that kT3 is affected by alterations in metabolic status, independent of changes in circulating TBG values. In these same subjects, kT4 was affected similarly by alterations in metabolic status, but kT4 was also altered by changes in serum TBG levels. The point at which the urinary ' ¶I/I values formed a linear exponential slope can be taken as the time when the Ts tracer had achieved full equilibration; this time interval was observed to be 22 hr in euthyroid subjects. It was not significantly altered in any of the study groups except in those patients with high TBG levels and patients with primary hypothyroidism; in these groups Ts equilibrium was prolonged for approximately 10 hr beyond the normal control values.
The second phase was marked by the 'I/I urinary ratio values forming a linear slope on semilogarithmic coordinates (as illustrated in Figs. 1 and 2 ). Since this slope ('Ts/T4) represented the ratio of the fractional turnover rates of the labeled precursor hormones (i.e., 'I-Ts and 'I-TA), it was possible to mathematically derive the fractional turnover rate of serum 'I-Ta by the following analysis:
Assuming that the urinary I/'I slope was the result of two declining exponential functions, the mathemati- cal expression for the ratio of two different equations can be written: (1) 1261 Aie-lkT3* -A3e-UkT3/T4t, 1311 =~7k 4 where 'I and 'I represent urinary 'I and 'I values at any time t; A&, A2, and As are constants, 'Ts and UkT4 are the urinary fractional turnover rates for 'I-Ts and I-T4, respectively. Thus: (2) -(UkT3 -UkT3) = UkT3/T4,
UkT4 + UkT3/T4 = UkT3 = kT3, where`Ts/T4 can be obtained directly from the urinary ratio slope and`UT4 can be assumed to equal the fractional turnover rate of T. measured in serum (kT4). As seen in Fig. 1 and Table I , 'Ts values closelycorrelated with (r = 0.91, P < 0.001) the corresponding serum kTs measurements. This served to verify the accuracy of the direct serum kT8 measurements. Although kTs and 'T8 were similar, it is of interest that 'Ts values were generally less than the corresponding serum kT3 determinations. This difference, which averaged 7.3% in all of the study groups, was found to be significant on paired t test (P < 0.001). It probably can be accounted for, in part, by the distorting effect of 'I iodoproteins produced from the labeled Ts (6) . Assuming that the fraction degradation rate of the labeled iodoprotein is much less than that of labeled triiodothyronine, it would be expected that gross alterations in urinary 'I/I ratio slope values would not be seen until the majority of the injected 'I-T3 tracer had disappeared. Indeed, a loss of linearity of the urinary slope values was not observed until 5-10 days after the injection of 'I-T8 tracer which denoted the beginning of the third phase. The UkT3/T4 value in the second phase also provided an index of the relative fractional turnover rates of I-T3, as compared to FI-TH. A marked increase in this ratio value was noted in the factitial hyperthyroid and toxic Graves' disease groups, while lower values were evident in the patients with primary hypothyroidism and those with idiopathically low TBG levels. A rise in the "Ta/T4 value would indicate that the change in fractional turnover rate for Ts was greater than that for T4. It is apparent from Table I and Fig. 2 that hyperthyroidism accelerates Ts degradation to a greater degree than To and that the reverse is true in hypothyroidism. An exception was the decrease in the UkTa/T4 values seen in the idiopathic low TBG group which resultedfrom an increase in T. degradation rather than a decrease in the Ts degradation.
In the third phase, the urinary ratio values were observed to become fixed or to rise with time. This Thyroxine and Triiodothyronine Kinetics indicated that the precursor to the 'I-iodide in the urine possessed a biological half-life greater than that of 'I-T, or, in other words, greater than 7 days on the average. This would be consistent with the estimated biological half-life of 12-15 days for the albumin-like labeled material produced as a by-product of Ta degradation (6) .
Distribution space of T. (Ta DS) and T4 (T4 DS). In euthyroid subjects Ta DS was 38.4 ±0.8 liters and the To DS was 11.6 ±0.6 liters (±SEM). The Ts DS was increased to 64.5 ±9.5 liters in the low TBG group and to 54.4 ±6.6 liters in the thyrotoxic Graves' disease patients, while it was reduced to 26.0 ±2.4 liters in subjects with elevated TBG values. The Ts DS was not significantly altered in the other study groups. It should be noted that the TBG levels in hypothyroid patients were not significantly different from those seen in the control group. The T4 DS generally paralleled the alterations in Ta DS in the various clinical states studied, but the changes were small and with the exception of subjects with elevated TBG levels, were not statistically significant.
The ratio of Ts DS/T& DS was 3.31 in the euthyroid group and was not changed in subjects with altered TBG levels. There was a tendency in hyper-and hypothyroid states for respective increases and decreases in this ratio value to occur (4.15 in hyperthyroid Graves', 2.55 in primary hypothyroid subjects, P < 0.05). Thus, it appears that alterations in circulating TBG levels similarly affect the distribution spaces for Ts and T4, while changes in nietabolic state alter Ta DS to a greater extent than To DS. Additionally, an increased Ta DS/Ts DS ratio of 4.41 was observed in hypothyroid Graves' disease subjects.
T. and T7 clearances. In the euthyroid group, Ts clearance was found to be 26.1 +1.5 liters and To clearance to be 1.3 +0.09 liters/day. In thyrotoxicosis, Ts and To clearances were both significantly increased to 60 and 2.8 liters and the converse of 18.5 and 1.35 liters was present in the hypothyroid patients. In the group with elevated TBG values, Ts and T4 clearances were decreased to 0.62, while they were markedly increased in two subjects with low TBG levels.
Metabolic clearance rate determinations. In five study subjects (two controls, two hypothyroid, and one hyperthyroid patient), Ta metabolic clearance rate was determined by employing a constant infusion of 'SI-Ts.
Generally, there was excellent correlation (r = 0.96, P < 0.01) between the values as determined by the pulse tracer technique and the constant infusion method (Table I) .
Hormonal production. In the euthyroid control group, daily blood production rates were 28 ,Ag for Ta and 88 i.g for T4. As might be expected, these values were not altered in euthyroid subjects with idiopathically high or low TBG values. In contrast, a 31-fold increase in To and over a 7-fold increase in Ts production rate was found in the thyrotoxic Graves' disease patients which gave a ratio of Ts to To production of 0.64 (P < 0.05). This preferential Ta production was seen most prominently in the hypometabolic Graves' disease patients where the Ts to To production ratio was increased to 0.81. In the primary hypothyroid group, there was a 4-fold decrease in both Ta and T, production rates.
DISCUSSION
The method for measurement of serum Ta kinetics described in this study appears to combine both technical simplicity and accuracy. Although solvent extraction methods (6, 12) could have been employed, the anion exchange column system proved to be less time consuming and more reproducible to cleanly separate labeled iodoproteins and iodothyronines. Substantiation that the column method achieved this goal was revealed by the following findings: The fractional turnover rates observed for Ts in this study substantially differed from those reported by Woeber, Sobel, Ingbar, and Sterling (5) in hyperthyroidism and by Zaninovich, Volpe, and Ezrin in subjects with altered TBG states (4) . Either the failure to appreciate (4), or adequately compensate for (5) , the presence of iodoproteins formed from Ts degradation may have been responsible for these differences. With the exception of the limited data reported by Surks and Oppenheimer (6) , it is evident that all previously reported labeled Ts disappearance curves, whether in serum (2) (3) (4) (5) (13) (14) (15) or in the whole body studies (16) , suffer from the same technical problem of failure to eliminate the influence of iodoproteins.
Estimates of Ts distribution space (Ts DS) may be in error since the single compartmental model system used in this study assumes that Ts disposal during equilibration is the same as after equilibration. The observed rise in urinary 'I/I ratio values during the equilibration phase (Figs. 1 and 2) indicated that Ts deiodination was substantially less during than after equilibration. Since deiodination constitutes the major route of-degradation for Ts, this would result in an underestimation of Ts disposal during the equilibration and, in turn, would cause an underestimation of Ts DS. On the other hand, the serum Ts disappearance slope during the equilibration phase may reflect the clearance of the Ts tracer, and this must be considered in calculating MCR. This error can be compensated for by using a two compartmental model (9) . An apparent 20% overestimation of Ts DS would result in normal subjects if a single rather than a two compartmental model system were used (15) .
In spite of these potential shortcomings, the magnitude of error in calculating MCR using the single compartmental model method would not appear to be great. Similar MCR values were obtained in five of our subjects by the constant infusion method which does not suffer from these technical handicaps. Moreover, Cavalieri, Steinberg, and Searle (17) have recently presented values for Ts MCR using the constant infusion method in normal and Graves' disease subjects which closely approximated the values seen in our patient population. Their Ts MCR values were 26.0 liters/day in euthyroid and 52.3 liters/day in toxic Graves' disease subjects while our values were 26.1 liters/day and 60.0 liters/day, respectively. The reason that the single compartmental model model appears to satisfactorily approximate Ts clearance is that the loss of the Ts tracer during the equilibration phase appears to be relatively small until the tracer approaches its ultimate distribution volume. In other words, the rapid equilibrating compartments do not represent major sites for Ts disposal.
Comparison of Ta and T4 kinetics revealed differences as well as similarities in peripheral metabolism. It was observed that kTa and kTi were altered in a parallel manner by changes in metabolic rate and TBG levels, but that alterations in metabolic status seemed to influence kT8 to a greater extent than kT&, while changes in TBG altered kT4 to a greater degree than kTa. Since Ts and T4 appear to be bound by TBG extracellularly, it is fair to assume that the extracellular distribution space for Ts is equal to that of T4, or about 5 liters (18) . Thus, only about 15% of the entire extrathyroidal Ts pool would appear to be extracellular. It is not surprising, therefore, that Ts is affected by changes in metabolic status since it is predominantly an intracellular hormone. On the other hand, approximately 50% of the T4 is in the extracellular fluid compartment bound to TBG (18) , and it is equally logical that TBG alterations will influence kT4 to a greater degree than kT3. Therefore, one may conclude that the differences in the magnitude of change in kT3 and kT4 observed in the various study groups are best explained by the differences in the extrathyroidal distribution of these two hormones. Oppenheimer, Schwartz, Shapiro, Bernstein, and Surks have come to essentially the same conclusions from the study of Ts and T4 peripheral metabolism in four euthyroid subjects (19) . However, several other aspects of Ts and T4 peripheral metabolism are less clear. For instance, why is the Ts distribution space 31 times greater than that for T4? Since the extracellular binding for Ts and T4 are predominantly to TBG and the intrahepatic distribution space for T. is estimated to be greater than that for Ts (20) , this difference is even more puzzling. Additionally, why was Ts equilibration delayed as long as 22 hr in euthyroid subjects? Presumably this relates to the slow entrance of Ts into the extrahepatic intracellular compartment. As has been observed by Cavalieri, Steinberg, and Searle (20) , the egress of T8 into this compartment is quite slow and, as we confirmed in the present study, is not altered by hypermetabolic states or by decreases in circulating TBG concentrations. Thus, it would appear that future investigation will be necessary to solve these puzzling observations.
The measurement of Ts concentration in the serum has been technically difficult and still must be considered an area of controversial investigation (21) (22) (23) (24) (25) (26) (27) . It would appear that the values previously reported by the method of Sterling, Bellabarba, Newman, and Brenner may be erroneously high (23) . We have recently developed a double-column chromatographic method for measurement of serum Ts concentration which allowed correction for some of the methodological artifacts, particu-Thyroxine and Triiodothyronine Kinetics larly the monodeiodination of T4 to Ts (28) . This has provided a more accurate assessment of serum Ta concentration, but the correction factors are large and the results are, therefore, subject to some overcorrection, particularly at low serum Ts levels. The recent development of a radioimmunoassay method for measurement of serum T3 in unextracted serum would therefore appear to represent a substantial methodological improvement (11) .
The apparently inappropriately high kTs and kT4 values found in Graves' disease subjects with normal and subnormal T4 values, requires some further clarification. A high kT4 value relative to metabolic status in patients with treated Graves' disease was initially described by Ingbar and Freinkel (29) . Subsequent investigations have substantiated this observation and have indicated that an augmentation in hepatic T4 incorporation and degradation are probably responsible for the elevated kT4 values (30, 31) . Recently, Schussler and Vance (32) and Farmer, Smitherman, Beschi, and Pittman (33) have demonstrated that Ts administration to euthyroid subjects, in replacement or subreplacement doses, is capable of increasing kT4, implying that Ts is capable of increasing the rate of T4 degradation. Additionally, Sterling and coworkers have reported elevated serum Ta values in treated Graves' disease subjects in whom serum T4 values have returned to normal or hypothyroid levels (23) . In the present study the following observations would appear to be relevant: (a) increases in the Ta DS/T4 DS and T3/T4 production ratios were found in the hypothyroid Graves' disease group; (b) a positive correlation between Ts production rate and kT4 was observed (r = 0.72, P < 0.001) when excluding altered TBG states; (c) two thyrotoxic Graves' disease patients, who displayed normal free and total T4 values with elevated serum Ta levels, had rapid T3 and T4 kinetics similar to those of the remainder of the patients with thyrotoxic Graves' disease; (d) patients with factitial thyrotoxicosis evidenced the same kinetic changes for T3 and T4 as were observed in the thyrotoxic Graves' disease group. Thus, it would appear that the presence of a large fractional turnover rate for T4 in treated Graves' disease patients may not represent, as previously speculated, an expression of "an integral part of this disorder per se" (34) , but rather it is probably a manifestation of a preferential Ts secretion present in this condition.
It is evident from the foregoing discussion that T3 production plays a major role in determining the pattern of Ta and T4 kinetics. Additionally, T3 production would appear to have a considerable influence on peripheral hormone action. If one assumes that Ta has 4 times the metabolic potency of T4, then T3 might account for more than half of all hormonal activity pro-duced in euthyroid subjects and, in the case of Graves' disease patients, it could account for better than three fourths of total hormonal action. This preeminent role of T3, both in normal and pathological states, would suggest the importance of this hormone in assessing thyroid status in man.
